CYP2E1 and metabolic dysfunction-associated steatohepatitis: CYP2E1 and CYP4A appear to play significant roles in the development of NAFLD/NASH by promoting the accumulation of lipid, inflammation, and fibrosis through the generation of ROS and NADPH-dependent microsomal lipid peroxidation (43).